ONESOURCE Share Price Performance
₹1,874.20
164.20 (9.60%)
Price ₹1,874.20
Share Price₹1,874.20
ONESOURCE Community Narratives
There are no narratives available yet.
Recent ONESOURCE News & Updates
No updates
OneSource Specialty Pharma Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -1.04
- Gross Margin
- 70.99%
- Net Profit Margin
- -0.81%
- Debt/Equity Ratio
- 16.0%
OneSource Specialty Pharma Limited Competitors
About ONESOURCE
- Founded
- 2007
- Employees
- 1250
- CEO
- WebsiteView website
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India and internationally. The company provides end-to-end CDMO services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products. OneSource Specialty Pharma Limited was formerly known as Stelis Biopharma Limited and changed its name to OneSource Specialty Pharma Limited in February 2024. The company was incorporated in 2007 and is based in Bengaluru, India.
Indian Market Performance
- 7 Days: -1.7%
- 3 Months: 4.9%
- 1 Year: -4.7%
- Year to Date: -1.5%
Over the last 7 days, the market has dropped 1.7%, driven by a loss of 1.3% in the Communication Services sector. The market has dropped 4.7% in the last year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading